Anti-CD52 antibody treatment depletes B cell aggregates in the central nervous system in a mouse model of multiple sclerosis

Overview of attention for article published in Journal of Neuroinflammation, August 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

blogs: 1 blog

twitter: 2 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 53 Mendeley

Summary Blogs X Dimensions citations

So far, Altmetric has seen 1 blog post.

Will They, Won't They

Multiple Sclerosis Research, 29 Aug 2018

Following the approval of ocrelizumab for progressive MS, it stands to reason that alemtuzumab will also be similarly…